RNU1-128P

Q-omics provides the consensus-scored RNU1-128P profile across patient tissues and cancer cell-line models. RNU1-128P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, RNU1-128P RNA expression shows 1,393 significant gene co-expression associations, with the highest sampling consensus in OV. Together, these results highlight PAAD, and OV as cancer lineages where RNU1-128P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNU1-128P survival associations across molecular data types. RNU1-128P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU1-128P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	PAAD (18)	view →

This table ranks reproducible RNU1-128P RNA expression–survival associations across cancer types. High RNU1-128P expression shows unfavorable associations in PAAD. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .040). Together, the overview and detailed table identify PAAD as the clearest survival context for RNU1-128P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.216	0.613	.040	18	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RNU1-128P-PAAD (OS)

Explore this curve interactively →